Bridging innovation and risk: the missing role of validated risk-stratification in IgE-mediated food allergy management
{{output}}
Over the last decade, the prevalence of IgE-mediated food allergies has increased, alongside therapeutic innovations such as oral immunotherapy (OIT), omalizumab, combination approaches, intranasal epinephrine, and emerging biomarker-guided strategies. This mi... ...
